ASSOCIATION BETWEEN THE CYP3A4*22 ALLELE AND THE PHARMACOKINETICS OF THE CYP3A4 PHENOTYPING PROBES MIDAZOLAM AND ERYTHROMYCIN IN CANCER PATIENTS.

Elens, Laure

ASSOCIATION BETWEEN THE CYP3A4*22 ALLELE AND THE PHARMACOKINETICS OF THE CYP3A4 PHENOTYPING PROBES MIDAZOLAM AND ERYTHROMYCIN IN CANCER PATIENTS.

(2012) 113th Annual Meeting of the American-Society-for-Clinical-Pharmacology-and-Therapeutics (ASCPT) — Location: Washington, USA (14.March.2012)

Files

No attached file found for this publication.

Details

Authors

Elens, LaureUCLouvain
Author

Affiliations

UCLouvainSSS/LDRI - Louvain Drug Research Institute

Citations

APA
Chicago
FWB

Elens, L. (2012). ASSOCIATION BETWEEN THE CYP3A4*22 ALLELE AND THE PHARMACOKINETICS OF THE CYP3A4 PHENOTYPING PROBES MIDAZOLAM AND ERYTHROMYCIN IN CANCER PATIENTS. Clinical Pharmacology and Therapeutics, 91(S1), S107. https://hdl.handle.net/2078.5/80453 (Original work published 2012)